| POLAR CAPITAL BIOTECHNOLOGY I USD DIS | RVI BIOTECNOLOGÍA | 67,903268 | 16/09/2026 | 18,29% | 91,10% | **** |
| MIRALTA NARVAL EUROPA, FI C | RVI EUROPA | 252,034844 | 16/09/2026 | 15,10% | 91,09% | ***** |
| SCHRODER ISF JAPANESE OPPORTUNITIES I ACC USD (HEDGED) | RVI JAPÓN VALOR | 62,693248 | 16/09/2026 | 28,49% | 91,06% | **** |
| JANUS HENDERSON HF - BIOTECHNOLOGY H2 EUR HEDGED | RVI BIOTECNOLOGÍA | 31,560000 | 16/09/2026 | 13,04% | 91,04% | **** |
| SANTANDER ACCIONES ESPAÑOLAS, FI CARTERA | RV ESPAÑA | 56,801625 | 15/09/2026 | 10,60% | 91,01% | ** |
| CANDRIAM EQUITIES L ROBOTICS & INNOVATIVE TECHNOLOGY C CAP EUR | RVI TECNOLOGÍA | 603,650000 | 16/09/2026 | 33,51% | 90,97% | *** |
| MAGALLANES VALUE INVESTORS UCITS-IBERIAN EQUITY-R | RV ESPAÑA | 271,197800 | 15/09/2026 | 11,79% | 90,96% | ** |
| GOLDMAN SACHS US TECHNOLOGY OPPORTUNITIES EQUITY PORTFOLIO OTHER CURRENCY EUR CAP | RVI TECNOLOGÍA | 24,060000 | 16/09/2026 | 21,76% | 90,95% | *** |
| MATTHEWS ASIA FUNDS-JAPAN FUND IH CAP USD | RVI JAPÓN | 36,326601 | 16/09/2026 | 22,65% | 90,91% | ***** |
| POLAR CAPITAL BIOTECHNOLOGY I GBP DIS | RVI BIOTECNOLOGÍA | 67,914626 | 16/09/2026 | 18,17% | 90,91% | ***** |
